Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
Oral Drug Delivery Systems: Delayed-Release Systems01:11

Oral Drug Delivery Systems: Delayed-Release Systems

Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Both trait-neutrality and filtering effects are validated by the vegetation patterns detected in the functional recovery of sand grasslands.

Scientific reports·2018
Same author

Thermoluminescence characterization of Ag-doped Li<sub>2</sub> B<sub>4</sub> O<sub>7</sub> single crystal materials.

Luminescence : the journal of biological and chemical luminescence·2016
Same author

Long-term adjunctive lacosamide treatment in patients with partial-onset seizures.

Acta neurologica Scandinavica·2015
Same author

Origin and compensation of imaging artefacts in localization-based super-resolution microscopy.

Methods (San Diego, Calif.)·2015
Same author

LGI Proteins and Epilepsy in Human and Animals.

Journal of veterinary internal medicine·2015
Same author

Study of the compressibility of chewing gum and its applicability as an oral drug delivery system.

Pharmaceutical development and technology·2015

Related Experiment Video

Updated: May 26, 2026

Formation of Dispersible Taohong Siwu Tablets
05:44

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

Formulation study of directly compressible chewable polymers containing ascorbic acid.

P Kása1, I Jójárt, A Kelemen

  • 1Department of Pharmaceutical Technology, Szeged, Hungary.

Pharmaceutical Development and Technology
|January 11, 2012
PubMed
Summary
This summary is machine-generated.

This study investigated the compression physics of gum bases for direct tablet compression. Increasing compression force did not significantly alter the physical tablet properties, suggesting robust formulations.

More Related Videos

Calcium Carbonate Formation in the Presence of Biopolymeric Additives
09:31

Calcium Carbonate Formation in the Presence of Biopolymeric Additives

Published on: May 14, 2019

Related Experiment Videos

Last Updated: May 26, 2026

Formation of Dispersible Taohong Siwu Tablets
05:44

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

Calcium Carbonate Formation in the Presence of Biopolymeric Additives
09:31

Calcium Carbonate Formation in the Presence of Biopolymeric Additives

Published on: May 14, 2019

Area of Science:

  • Pharmaceutical technology
  • Materials science

Background:

  • Direct compression is a common method for manufacturing tablets.
  • Gum bases are essential excipients in pharmaceutical formulations, particularly for chewable tablets.

Purpose of the Study:

  • To evaluate the compression physics of different gum bases (Pharmagum C, M, S) for direct compression tablet manufacturing.
  • To determine the impact of varying compression forces on the physical properties of tablets prepared from these gum bases.

Main Methods:

  • Three distinct gum bases were tested individually and in combination.
  • Tablets were prepared using a Korsch EK0 eccentric tableting machine.
  • Compression forces ranged from 5 to 15 kN, and tablet parameters were analyzed.

Main Results:

  • The physical parameters of the compressed tablets, including compression and breaking characteristics, were investigated.
  • An increase in compression force did not lead to significant changes in the measured tablet properties.
  • This indicates a degree of stability in the tablet formulations across the tested force range.

Conclusions:

  • The tested gum bases exhibit predictable compression behavior under direct compression.
  • Formulations using these gum bases are likely to maintain consistent physical characteristics regardless of moderate variations in compression force.
  • Further research could explore other critical process parameters and their influence on gum base tablet properties.